Fatimah Javaid Qureshi, Muhammad Anwar, Muhammad Asif Nawaz, Mehnaz Omer, Sanober Hameed, Saqibah Rehman
{"title":"Risk Assessment of Cardiovascular Atherogenicity in Growth Hormone-Deficient Children.","authors":"Fatimah Javaid Qureshi, Muhammad Anwar, Muhammad Asif Nawaz, Mehnaz Omer, Sanober Hameed, Saqibah Rehman","doi":"10.29271/jcpsp.2025.10.1284","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To assess cardiovascular atherogenic risk in children with growth hormone deficiency (GHD) by comparing lipid profiles and plasma atherogenic indices (PAI) with those of healthy controls.</p><p><strong>Study design: </strong>A comparative cross-sectional study. Place and Duration of the Study: Department of Chemical Pathology, the Armed Forces Institute of Pathology, Rawalpindi, Pakistan, from February to July 2024.</p><p><strong>Methodology: </strong>Ninety children with short stature, aged 3-12 years were evaluated. They were categorised into the growth hormone-deficient group (GHD group) and the healthy control group (Control group) based on the insulin tolerance test, IGF-1, and IGFBP-3 levels. Fasting lipid profiles were assessed, including total cholesterol (TC), triglyceride (TG), high-density lipoprotein (HDL), low-density lipoprotein (LDL), and non-HDL cholesterol. The PAI was calculated as log (TG/HDL). Data were analysed using SPSS version 23. The independent t-test and Mann-Whitney U test were used to compare continuous variables between the two groups, whilst the Chi-square test was applied for categorical variables. Statistical significance was set at p ≤0.05.</p><p><strong>Results: </strong>Among the 90 participants, 48 exhibited GHD and 42 were healthy. Children with GHD showed markedly increased TC, TG, LDL, non-HDL cholesterol, and PAI values (p <0.001). Their HDL levels were also reduced compared with those of the healthy controls. A substantial proportion of GHD children (77.8%) were classified as high-risk based on PAI, whilst 100% of those with elevated non-HDL cholesterol were GHD. Atherogenic lipid parameters demonstrated a negative correlation with IGF-1 levels (p <0.001). IGF-1 concentrations correlated favourably with GH and HDL basal concentrations.</p><p><strong>Conclusion: </strong>Children with GHD exhibited dyslipidaemia and elevated atherogenic risk markers, indicating a predisposition to premature atherosclerosis.</p><p><strong>Key words: </strong>Cardiovascular disease, Growth hormone, Dyslipidaemia, Plasma atherogenic indices.</p>","PeriodicalId":94116,"journal":{"name":"Journal of the College of Physicians and Surgeons--Pakistan : JCPSP","volume":"35 10","pages":"1284-1288"},"PeriodicalIF":0.8000,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the College of Physicians and Surgeons--Pakistan : JCPSP","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.29271/jcpsp.2025.10.1284","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: To assess cardiovascular atherogenic risk in children with growth hormone deficiency (GHD) by comparing lipid profiles and plasma atherogenic indices (PAI) with those of healthy controls.
Study design: A comparative cross-sectional study. Place and Duration of the Study: Department of Chemical Pathology, the Armed Forces Institute of Pathology, Rawalpindi, Pakistan, from February to July 2024.
Methodology: Ninety children with short stature, aged 3-12 years were evaluated. They were categorised into the growth hormone-deficient group (GHD group) and the healthy control group (Control group) based on the insulin tolerance test, IGF-1, and IGFBP-3 levels. Fasting lipid profiles were assessed, including total cholesterol (TC), triglyceride (TG), high-density lipoprotein (HDL), low-density lipoprotein (LDL), and non-HDL cholesterol. The PAI was calculated as log (TG/HDL). Data were analysed using SPSS version 23. The independent t-test and Mann-Whitney U test were used to compare continuous variables between the two groups, whilst the Chi-square test was applied for categorical variables. Statistical significance was set at p ≤0.05.
Results: Among the 90 participants, 48 exhibited GHD and 42 were healthy. Children with GHD showed markedly increased TC, TG, LDL, non-HDL cholesterol, and PAI values (p <0.001). Their HDL levels were also reduced compared with those of the healthy controls. A substantial proportion of GHD children (77.8%) were classified as high-risk based on PAI, whilst 100% of those with elevated non-HDL cholesterol were GHD. Atherogenic lipid parameters demonstrated a negative correlation with IGF-1 levels (p <0.001). IGF-1 concentrations correlated favourably with GH and HDL basal concentrations.
Conclusion: Children with GHD exhibited dyslipidaemia and elevated atherogenic risk markers, indicating a predisposition to premature atherosclerosis.